- Posted By: Susan Wagland
On-site monitoring: triggered or random?
How can we prioritise sites for on-site monitoring to target those that present the highest risk, and use trial resources most efficiently?
How can we prioritise sites for on-site monitoring to target those that present the highest risk, and use trial resources most efficiently?
The 4 different Research Government Frameworks (RGF) (one for each of the 4 UK different countries) have been replaced by a new and one Framework labelled the UK Policy Framework for Health and Soc
Earlier in September I attended the annual MHRA GCP one day symposium where the agenda focused on the following activities:
• Oversight – Trial and System Design
I attended the UK TMN Annual Meeting this week. I’ve been to several of the workshops/talks run by UK TMN (which I’ve always found useful), but this was my first annual meeting.
Today (12th October) Prof. R. Holman (Director) & Steven Richards (Software Validation Manager), Diabetes Trials Unit hosted the second Oxford CRC IT Group meeting.